ImpriMed Secures $23 Million in Series A Funding to Revolutionize Cancer Treatment with AI
Key Highlights ImpriMed has closed a $23 million Series A funding round led by SBVA, with participation from multiple investors including…
Browsing Tag
SBVA
1 post